Oyster Point Pharma OverviewOyster Point Pharma Net Income
Profitability analysis for OYST.
Quarterly Net Income
-$40.24M
↓ 127.74% YoY
As of Sep 2022
Annual Net Income (TTM)
-$188.97M
↓ 133.8% YoY
Trailing 12 months ending Sep 2022
Average Net Income (Comparison Companies)
Net Income History
Net Income Comparison
Annual Net Income Growth Rate (%)
Loading...
Annual Net Income Growth (Absolute)
Loading...